Main menu

IBM added to its stable of proteomics partners last week in a deal that makes it GeneFormatics preferred information technology and services partner. As part of the deal, IBM made an equity investment in GeneFormatics Series C round of financing.

The amount of IBMs investment was not disclosed.

Get the full story with GenomeWeb Premium

Only $95 for the first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.